TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: change in lesion size (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative abundance of Bacteroides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Stool concentrations of short chain fatty acids (SCFAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Beneficiary depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Occurrence of seizure
Endpoint domain: Mortality/survival
Primary endpoint: Duration of inpatient admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of side effects from magnesium sulfate
Endpoint domain: Adverse events/effects
Primary endpoint: change in social quotient
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Prostate-specific antigen disease control rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematologic toxicity (platelet decrease)
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: motor competency improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in serum 25‐hydroxyvitamin D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Semen quality improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: FLI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scapular dyskinesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of injury to the CPN
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of injury to the first branch of the CPN
Endpoint domain: Adverse events/effects
Primary endpoint: manual ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of severe cholera
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of postoperative ileus (POI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Regular bowel sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: SU levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: eGFR effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: mean sustainability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in low-density lipoprotein cholesterol (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean change in pain NRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour average glucose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Brachial artery flow-mediated dilation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Function improvements from home-based video game exercises
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of cysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ovarian volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hirsutism levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for additional pain medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Walter Reed Visual Assessment Scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: myocardial and brain injury indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tracheal extubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of CMV replication
Endpoint domain: Adverse events/effects
Primary endpoint: Composite score of psychotic symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive taste response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of surgeons who took blank shots
Endpoint domain: Adverse events/effects
Primary endpoint: Total average blank shots
Endpoint domain: Adverse events/effects
Primary endpoint: overall incidence of coagulase‐negative staphylococcal TJA PJIs
Endpoint domain: Adverse events/effects
Primary endpoint: relative incidence of MSSA TJA PJIs
Endpoint domain: Adverse events/effects
Primary endpoint: overall incidence of MRSA TKA PJIs
Endpoint domain: Adverse events/effects
Primary endpoint: Normalized serum 25‐OHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right-sided adenoma detection rate (ADR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Head Circumference (HC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of overweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Systemic immune responses (IgA serum antibody dominance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mucosal antibody responses (specific IgA in stool samples)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety and tolerability of ShigETEC
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in total hip BMD per year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically relevant bleeding (CRB)
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life (EQ-5D-5L utility score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of cam resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-stenosis requiring a re-interventional procedure within 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Ankle Brachial Pressure Index (ABI) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clarity of precision prevention materials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cumulative stool frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Weight trajectories from 20 weeks gestation to 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Abdominal circumference trajectories from 20 weeks gestation to 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Implantation depth (ID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median air leakage pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptomatic remission at Week 152
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corticosteroid-free symptomatic remission rates at Week 152
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biochemical evidence of response (C-reactive protein and faecal calprotectin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive improvement on a measure of facial memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difficulty understanding treatment explanations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive value for abnormal bone mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h urinary excretion of citrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 24-h urinary excretion of magnesium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Patency rates of great saphenous vein bridge and internal mammary artery bridge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of gastrointestinal adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Agitation-related events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of long-term antidepressant use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ePFS (event-free survival)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDAI score at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSQM score at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PEPPI score at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: oxidation of l-[1-13C]phenylalanine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: clinical outcomes of patients treated with both conventional- and intermediate-size THVs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of CFUs (colony-forming units) of E. faecalis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: death or serious respiratory morbidity
Endpoint domain: Mortality/survival
Primary endpoint: death or moderate–severe neurodevelopmental impairment
Endpoint domain: Mortality/survival
Primary endpoint: Participant satisfaction with the study
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rates of wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: Favorable functional outcome (modified Rankin Scale score ≤ 2)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Development of delayed cerebral ischemia (DCI)
Endpoint domain: Adverse events/effects
Primary endpoint: patient satisfaction with surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: functional outcome with surgery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: trochanteric pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pretest probability for obstructive sleep apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of CIN2/3
Endpoint domain: Mortality/survival
Primary endpoint: Serum insulin values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Infant growth (weight-for-age z scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total CIPNAT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: FEV1 score at 48 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: temporal swing symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade ≥3 Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: dyspnea-related ticagrelor discontinuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subsequent ischemic events (composite of all-cause death, myocardial infarction, or stroke)
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of Latinx populace being tested
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased fentanyl consumption of the PCA bolus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in rescue analgesic use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Better patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of database-screening tools for recruitment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: early recurrence after breast cancer surgery
Endpoint domain: Mortality/survival
Primary endpoint: Deep vein thrombosis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: long-term psychological and somatoform complaints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Causal relationship between snoring and whole-body fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Causal relationship between dozing and right leg fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Causal relationship between right arm fat mass and snoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of liver failure
Endpoint domain: Mortality/survival
Primary endpoint: Serum alanine transaminase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Number of additional glaucoma surgeries
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Office visits during the first 3 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: satisfaction with smoking experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: intentions for continued use
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: total inhaled volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predicting systemic recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Completion of outcome measures at six-month follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Endothelial function assessed by FMD of the brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of PE (preeclampsia)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in EPB from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Nighttime systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of needle attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: practitioners’ skills in MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCA percent increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in externalizing scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of patient admission documentation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dictation time for discharge records
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: surface wear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage body weight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Crying or fussing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days with colic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregivers' PSS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Opioid use in the 24 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAP variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of SpO2 falling below 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: numbness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tingling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptom severity scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Injection technique scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in lung damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time Up and Go (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of inflammatory mediators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Attendance of fourth antenatal care visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MEDs consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-DR survival
Endpoint domain: Mortality/survival
Primary endpoint: Bioequivalence of lisinopril and amlodipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax and AUC of lisinopril
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrahepatic lipid content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower rate of cervical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance of trunk muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: median gain in visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: headache pain-free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustained pain freedom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static lung compliance (Cstat)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Secretion mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exclusive Breastfeeding (EBF) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nocebo effect of any adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Nocebo effect of gastrointestinal-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Nocebo effect of musculoskeletal-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of ED visits for fall-related TBI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital admission rate for fall-related TBI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-ED mortality rate for fall-related TBI
Endpoint domain: Mortality/survival
Primary endpoint: Retention/fracture rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maneuverability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: limb fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum total T concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of TLR4, NF‐κB, and TNF‐α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in arm pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of stroke, systemic embolism, or cardiovascular/unexplained death
Endpoint domain: Mortality/survival
Primary endpoint: LAA occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Photoplethysmogram amplitude predictability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delay between tcVNS onset and cardiovascular effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of ulcer recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10 m MWS test value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Young's modulus values of multifidus muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: steady-state AUC0-24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean urinary excretion of 5-ASA plus N-Ac-5-ASA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction of nursing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Odds of breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: Identification of patients with NASH cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response speeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: valgus stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of hepatitis B flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Vision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean number of drops missed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with instillation ease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ICU or ward admission days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discharge rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes